SPB Shorts Keep Building Ahead of November 12 Earnings

Spectrum Brands heads into its November 12 earnings release with short sellers adding to positions at a steady clip, even as the stock has climbed 5.4% over the past week and 8.5% over the past month.

Short interest has become the defining tension here. At nearly 19.5% of the free float, it is a meaningfully high position for a mid-cap consumer staples name. More notable is the trajectory: short interest is up 20.5% over the past month and 4.4% over the past week alone, adding roughly 390,000 shares to the bet. That is a deliberate rebuild, not noise. The ORTEX short score has crept to 70.8, its highest level in the tracked window, up from 68.4 at the start of the observation period in late October. Despite that, the borrow market is not flagging urgency. Cost to borrow is just 0.41%, low by any measure, and availability is running at roughly 433%, meaning there are more than four shares available to lend for every one already borrowed. That compares to a 52-week minimum availability of around 189%. Shorts are building, but they face no meaningful squeeze pressure from the lending pool.

Options positioning reinforces the defensive read. The put/call ratio is 2.50, sitting just below its 52-week peak of 2.51. That is well above the 20-day average of 1.65, with a z-score of 1.06, meaning put demand has been elevated for weeks. The options market is not expressing a view that the stock is about to squeeze higher; it is expressing a desire for downside cover into the print.

The Street is broadly constructive but not uniform. The consensus is a buy, with four buy ratings and a mean price target of $98.75, implying roughly 16% upside from current levels at $85.01. The most recent action came from UBS on October 15, where Peter Grom reinstated coverage with a buy and a $97 target. Wells Fargo, by contrast, sits at equal-weight and trimmed its target from $90 to $85 in early October, the target now exactly matching the current price. Canaccord remains the most optimistic at $110. The bull case leans on EBITDA recovering toward $486 million for 2027 and a steady top-line recovery in home and personal care, pet care, and home and garden. The bear case points to the tariff-driven disruption from Chinese import constraints, softer consumer demand, and execution risk around free cash flow generation. At a P/E of 13.9 and EV/EBITDA of 7.8, the multiple has expanded modestly over the past month. EPS momentum scores are strong at 73 on a 30-day basis and 83 over 90 days, reflecting positive estimate revisions. The short score rank of 6 out of 100, however, flags that the stock ranks near the most-shorted end of its universe, a risk factor the bulls will need to price.

Institutional ownership is concentrated and mostly steady. Pzena Investment Management holds 10.5% and increased its stake through the most recent filing period. American Century added nearly 395,000 shares to reach 9.1% as of September 30. BlackRock increased its passive position to 8.4%. Callodine Capital, the fourth-largest holder at 7.6%, trimmed slightly. No 13D activist is on the register, a point worth noting given the size of some of these value-oriented positions. Stakes are as last disclosed around the 5% threshold, and holders can exit below that level without further filing.

One cross-asset data point worth noting: retail attention to Spectrum Brands, measured by Wikipedia page views and ORTEX page traffic relative to the past 90 days, registered a z-score of 2.27 as of late October, its most elevated reading in the recent window. Retail attention is not a revenue indicator, but it does suggest the stock is drawing more eyes than usual ahead of the report.

The closest peer, ENR, gained 5.9% on the week in line with SPB. KMB fell 4.3%, a reminder that the household products sector is not moving as one. The next eight days, and what management says about tariff exposure and the trajectory of the home and garden segment, will determine whether the short rebuild was well-timed or premature.